Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-04

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Pheochromocytoma, Extra-Adrenal

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Pheochromocytoma, Extra-Adrenal in 1 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, YH1
Conti, M1
Lee, YC1
Lai, HL1
Ching, YH1
Chern, Y1

Other Studies

1 other study available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Pheochromocytoma, Extra-Adrenal

ArticleYear
Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
    Journal of neurochemistry, 1997, Volume: 69, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenosine; Adre

1997